Hexobarbital

From WikiMD's WELLNESSPEDIA

(Redirected from Barbidorm)

Hexobarbital
Hexobarbital ball-and-stick
Hexobarbital synthesis.jpg
Hexobarbital synthesis through ester and urea
Enantiomers of Hexobarbital
Metabolic pathway of hexobarbital

Hexobarbital is a barbiturate derivative with anesthetic and sedative properties. It was first synthesized in the early 20th century and has been used in various medical applications, particularly as a general anesthetic and hypnotic agent.

Chemical Properties[edit]

Hexobarbital, also known as 5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid, is a white crystalline powder that is soluble in water and alcohol. Its chemical formula is C12H16N2O3, and it has a molecular weight of 236.27 g/mol.

Pharmacology[edit]

Hexobarbital acts on the central nervous system (CNS) by enhancing the activity of the gamma-aminobutyric acid (GABA) receptor, which is the primary inhibitory neurotransmitter in the CNS. This action results in sedation, hypnosis, and anesthesia. The drug has a relatively short duration of action compared to other barbiturates, making it suitable for procedures requiring brief periods of anesthesia.

Medical Uses[edit]

Hexobarbital has been used primarily as a general anesthetic for short surgical procedures. It has also been employed as a sedative and hypnotic for the treatment of insomnia and other sleep disorders. However, due to the development of newer and safer anesthetic agents, the use of hexobarbital has declined significantly.

Side Effects[edit]

Common side effects of hexobarbital include drowsiness, dizziness, and nausea. In higher doses, it can cause respiratory depression, hypotension, and bradycardia. Long-term use can lead to tolerance, dependence, and withdrawal symptoms.

Metabolism and Excretion[edit]

Hexobarbital is metabolized in the liver by the cytochrome P450 enzyme system and is excreted primarily in the urine. The drug has a half-life of approximately 3 to 6 hours.

History[edit]

Hexobarbital was first synthesized in the 1930s and was widely used during the mid-20th century. Its use has declined with the advent of newer anesthetic agents that offer improved safety profiles and fewer side effects.

See Also[edit]

References[edit]

External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.